Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation

scientific article

Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-3046.2008.00906.X
P698PubMed publication ID18282210
P5875ResearchGate publication ID5570405

P2093author name stringLarry A Greenbaum
Barry L Warshaw
Leonard C Hymes
Sandra G Amaral
P433issue7
P921main subjectsirolimusQ32089
P304page(s)773-777
P577publication date2008-02-15
P1433published inPediatric TransplantationQ7159217
P1476titleTacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation
P478volume12

Reverse relations

cites work (P2860)
Q3692959724 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
Q37821472Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
Q53702610Calcineurin inhibitors and nephrotoxicity in children.
Q43808149Conversion to sirolimus in pediatric renal transplant patients: a single-center experience
Q33394258Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation
Q38134146Growing experience with mTOR inhibitors in pediatric solid organ transplantation
Q44613261Linear growth in pediatric renal transplant recipients receiving sirolimus
Q47945773Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression
Q33397668Sirolimus in pediatric renal transplantation
Q37877294The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus
Q38112331mTOR inhibitors in pediatric kidney transplantation

Search more.